Palisade Bio (PALI) EBIT (QoQ) (2010 - 2026)
Palisade Bio (PALI) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.68% |
| Dec 31, 2025 | -241.58% |
| Sep 30, 2025 | -2.78% |
| Jun 30, 2025 | -23.07% |
| Mar 31, 2025 | 31.70% |
| Dec 31, 2024 | 5.87% |
| Sep 30, 2024 | 14.68% |
| Jun 30, 2024 | -14.65% |
| Mar 31, 2024 | -16.46% |
| Dec 31, 2023 | 16.52% |
| Sep 30, 2023 | -4.68% |
| Jun 30, 2023 | -42.70% |
| Mar 31, 2023 | 34.28% |
| Dec 31, 2022 | 12.80% |
| Sep 30, 2022 | -23.54% |
| Jun 30, 2022 | 8.13% |
| Mar 31, 2022 | 3.45% |
| Dec 31, 2021 | -33.52% |
| Sep 30, 2021 | 90.82% |
| Jun 30, 2021 | -1,581.58% |